Doctor profile · Federal record
Dr. ALI ABOUFARES, MD
Interventional Cardiology Physician (CMS: INTERVENTIONAL CARDIOLOGY) · Interventional Cardiology Physician · NEW YORK, NY
- NPI 1508837287
- MIPS 93.1 / 100 · 2023
- 30 yrs in practice
- Licensed in 2 states
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
115 E 57TH ST, SUITE 1240
NEW YORK, NY 100222049
(212) 319-3977
fax (212) 319-4263
Credentials & registration
- NPI registered
- January 2006 — 20 yrs on file
- Profile last updated
- May 2, 2016
- Year of graduation
- 1996 — 30 yrs since
- Specialty taxonomy
- 207RI0011X — NUCC code
- State licenses (2)
- New York #244925 · Pennsylvania #MD426289
- Medicaid (2)
- NY #02673063 · PA #1013506880001
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1508837287. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
2,643
Distinct HCPCS
10
Medicare allowed
$1,635,790
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 330 | 210 | $137 | |
37253 |
Ultrasound evaluation of blood vessel with review by radiologist, each additional vessel | 248 | 74 | $206 | |
J2785 |
Injection, regadenoson, 0.1 mg | 236 | 59 | $52 | |
93000 |
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 206 | 151 | $17 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 178 | 145 | $101 | |
93306 |
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 153 | 147 | $227 | |
93970 |
Ultrasound study of arm or leg veins with compression and maneuvers | 143 | 122 | $211 | |
A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose | 126 | 63 | $120 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 122 | 122 | $183 | |
76937 |
Ultrasonic guidance for blood vessel access | 105 | 81 | $47 |
In context: peer comparison
Among 43 peers in this city , average services per provider: 69. This provider delivers 38× the peer median.Open Payments
Industry payments received
All-time total
$21,735
Transactions
43
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| AngioDynamics, Inc. | 6 | $20,766.67 | |
| Boston Scientific Corporation | 9 | $314.72 | |
| PFIZER INC. | 5 | $106.36 | |
| Novartis Pharmaceuticals Corporation | 6 | $101.27 | |
| Medtronic, Inc. | 2 | $85.68 | |
| Bard Peripheral Vascular, Inc. | 3 | $83.29 | |
| Lexicon Pharmaceuticals, Inc. | 3 | $60.22 | |
| Merck Sharp & Dohme LLC | 2 | $43.34 | |
| Kestra Medical Technology Services, Inc. | 1 | $40.46 | |
| CORDIS US CORP. | 1 | $38.94 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $22.10 | |
| Janssen Pharmaceuticals, Inc | 1 | $19.15 | |
| AstraZeneca Pharmaceuticals LP | 1 | $17.25 | |
| Philips North America LLC | 1 | $16.55 | |
| Abbott Laboratories | 1 | $15.15 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,824
Patients
626
Total drug cost
$328,001
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Metoprolol Succinate | Generic | 357 | 134 | $6,283 |
| Atorvastatin Calcium | Generic | 238 | 74 | $2,925 |
| Amlodipine Besylate | Generic | 179 | 73 | $992 |
| Clopidogrel (Clopidogrel Bisulfate) | Brand | 160 | 58 | $1,592 |
| Isosorbide Mononitrate Er (Isosorbide Mononitrate) | Brand | 118 | 40 | $1,358 |
| Eliquis (Apixaban) | Brand | 113 | 35 | $120,692 |
| Entresto (Sacubitril/Valsartan) | Brand | 104 | 28 | $126,766 |
| Hydrochlorothiazide | Generic | 94 | 34 | $445 |
| Losartan Potassium | Generic | 88 | 35 | $1,139 |
| Xarelto (Rivaroxaban) | Brand | 77 | 23 | $63,162 |